Cargando…
May interferon λ be a novel therapeutic approach against COVID-19?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581317/ https://www.ncbi.nlm.nih.gov/pubmed/33129578 http://dx.doi.org/10.1016/j.mehy.2020.110351 |
| _version_ | 1783598952364376064 |
|---|---|
| author | Roohi, Azam Soroosh, Pejman |
| author_facet | Roohi, Azam Soroosh, Pejman |
| author_sort | Roohi, Azam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7581317 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75813172020-10-23 May interferon λ be a novel therapeutic approach against COVID-19? Roohi, Azam Soroosh, Pejman Med Hypotheses Letter to Editors Elsevier Ltd. 2021-01 2020-10-22 /pmc/articles/PMC7581317/ /pubmed/33129578 http://dx.doi.org/10.1016/j.mehy.2020.110351 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to Editors Roohi, Azam Soroosh, Pejman May interferon λ be a novel therapeutic approach against COVID-19? |
| title | May interferon λ be a novel therapeutic approach against COVID-19? |
| title_full | May interferon λ be a novel therapeutic approach against COVID-19? |
| title_fullStr | May interferon λ be a novel therapeutic approach against COVID-19? |
| title_full_unstemmed | May interferon λ be a novel therapeutic approach against COVID-19? |
| title_short | May interferon λ be a novel therapeutic approach against COVID-19? |
| title_sort | may interferon λ be a novel therapeutic approach against covid-19? |
| topic | Letter to Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581317/ https://www.ncbi.nlm.nih.gov/pubmed/33129578 http://dx.doi.org/10.1016/j.mehy.2020.110351 |
| work_keys_str_mv | AT roohiazam mayinterferonlbeanoveltherapeuticapproachagainstcovid19 AT sorooshpejman mayinterferonlbeanoveltherapeuticapproachagainstcovid19 |